Related Experiment Video
Updated: Aug 6, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Cefepime-induced Acute Liver Injury in a 5-Year-old Boy
Lael Mode1, Judith A Guzman-Cottrill1,2, Mikelle Bassett1,2
1From the School of Medicine.
Insights
A rare case of cefepime-induced acute liver injury in a child is presented. The liver injury resolved after discontinuing the antibiotic, highlighting a potential adverse effect of cefepime in pediatric patients.
Area of Science:
- Pediatric infectious diseases
- Hepatology
- Clinical pharmacology
Background:
- Cephalosporins are common antibiotics for pediatric infections.
- Cefepime, a fourth-generation cephalosporin, is generally safe in children.
- Acute liver injury is a rare but serious adverse drug reaction.
Observation:
- A pediatric patient developed acute liver injury.
- The patient was treated with cefepime for an infection.
- Cefepime was identified as the likely cause of the liver injury.
Findings:
- Cefepime-induced acute liver injury is a rare adverse event.
- Liver function normalized after cefepime discontinuation.
- This case highlights the importance of monitoring liver function in pediatric patients receiving cefepime.
Implications:
- Clinicians should be aware of the potential for cefepime-induced liver injury in children.
- Prompt recognition and discontinuation of cefepime can lead to recovery.
- Further research may be needed to understand the mechanisms of cefepime hepatotoxicity.
Abstract:
Cephalosporins are frequently used to treat pediatric infections and are overall well tolerated. Cefepime, a fourth-generation cephalosporin, has an excellent safety profile in pediatrics. We report a rare case of cefepime-induced acute liver injury in a pediatric patient, which resolved after antibiotic discontinuation.
More Related Videos
Related Concept Videos
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Cholecystitis

